Promising Early Data for Oral Inhibitor Buparlisib
GRACEcast
English - August 03, 2016 16:47 - 1 minute - 131 MB Video - ★★★★★ - 2 ratingsMedicine Health & Fitness Science cancer radiation cancergrace chemo chemotherapy education grace gracecast jack lung Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Using Immunotherapy as First-Line Treatment and in Combinations
Next Episode: Are There Less Toxic Alternatives to the Extreme Regimen
GRACE is happy to present the 8th video in our series ASCO 2016 Head and Neck Roundtable, Treating Head and Neck Cancer. Featuring Jared Weiss, MD, Joshua Bauml, MD, and Tanguy Seiwert, MD, this roundtable discussion, moderated by Dr. Weiss, highlights intriguing discussions regarding head and neck cancers from ASCO 2016.
Drs. Weiss, Bauml and Seiwert discuss the promising early data for the oral inhibitor Buparlisib.